Literature DB >> 22845334

Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.

Lou M Gallagher1, Peter R Ganz, Hong Yang, Debra A Kessler, Sheila F O'Brien, Brian S Custer, Michael P Busch, Roger Y Dodd, Susan L Stramer, Mark O Walderhaug, Richard A Forshee, Alan E Williams, Jay S Epstein, Steven A Anderson.   

Abstract

Mesh：

Year:  2012        PMID： 22845334     DOI： 10.1111/j.1537-2995.2012.03808.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  3 in total

Review 1.  Pathogen inactivation technologies for cellular blood components: an update.

Authors:  Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2014-07-21       Impact factor: 3.747

2.  Dengue in the context of "safe blood" and global epidemiology: to screen or not to screen?

Authors:  Marion C Lanteri; Michael P Busch
Journal:  Transfusion       Date:  2012-08       Impact factor: 3.157

Review 3.  Advancing Public Health Using Regulatory Science to Enhance Development and Regulation of Medical Products: Food and Drug Administration Research at the Center for Biologics Evaluation and Research.

Authors:  Marc Kusinitz; Emily Braunstein; Carolyn A Wilson
Journal:  Front Med (Lausanne)       Date:  2017-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.